No-Cost, No-Obligation Ethicon Physiomesh Attorney Case Review

Ethicon Physiomesh Attorney
Ethicon Physiomesh Lawsuit News

Ethicon Physiomesh Trials Delayed Until 2020

The need for proper evidence gathering and handling is causing a delay in Physiomesh multi-district litigation

Sunday, March 3, 2019 - The upcoming trials of Ethicon Physiomesh hernia repair device are being delayed past the September 2019 date and into early February 2020. The reason for the delay is due to challenges to the admissibility of certain expert witnesses. Proper evidence gather and handling could also be adding to the delays as each plaintiff in multi-district litigation is required to present the actual Physiomesh device that was removed intact or in fragments as well as tissue samples that they preserved after revision surgery. In May of 2018, a court ordered that Physiomesh or Physiomesh fragments retrieved during revision surgery be carefully handled and the specimens sent to Steelgate Inc., a Florida biomedical storage and management company. The level of degradation of the polypropylene woven device is critical in demonstrating how the device is attacked by the body's natural immune system. Ethicon Physiomesh device attorneys recommend speaking with national Physiomesh lawyers for a no obligation free consultation.

Physiomesh is composed of multiple layers, one intended to become absorbed into the underlying tissue and the other layers not. Polypropylene is a type of petroleum-based plastic that is known for its strength and flexibility, however, Physiomesh is so strikingly lightweight and thin that it deteriorates easily, shrinking, hardening and crumpling into multiple pieces. Physiomesh removal surgeons sometimes fail to find and remove all of the pieces that have dispersed within a patient's body cavity. Physiomesh patients report that surgeons have found Physiomesh fragments in multiple locations in the body. Some have traveled to the lower intestines, lacerating the organ and causing life-threatening blockages. Most times, however, polypropylene's incompatibility can cause serious infections that must be treated. Scientists writing for the National Institute of Health have concluded have that polypropylene may not be compatible with human tissue. Many of us know of polypropylene as the type of plastic that is microwaveable. Polypropylene plastic is also used in the plastic bags we use every day.

Over 1000 cases against Johnson & Johnson subsidiary Ethicon Inc, concerning the Ethicon Physiomesh device, have been consolidated into multi-district litigation. Many individuals that have been injured by the hernia repair mesh have consulted with a hernia mesh attorney and filed a claim to hold the company responsible for bringing a faulty medical device to market. In May of 2016, Ethicon issued an Emergency Voluntary Market Withdrawal of Physiomesh when they were made aware of an abnormally high percentage of their patients needing revision surgery, two to four times as many as their competition. Patients with Physiomesh complications report high fever, nausea, vomiting, redness, swelling, soreness and continuous sharp pains from Physiomesh failure.

More complete information about upcoming Physiomesh trials as well as multi-district litigation can be found by contacting a Physiomesh attorney and by visiting the web page for the United States District Court of the Northern District of Georgia, where the judge states, "Ethicon Physiomesh Flexible Composite Hernia Mesh products liability litigation involves claims that a particular hernia mesh product was allegedly defectively designed, manufactured, and labeled by Ethicon, Inc. and/or Johnson & Johnson and caused personal injuries to plaintiffs. The specific device at issue in this litigation is PHYSIOMESH Flexible Composite Mesh. This litigation does not involve PHYSIOMESH Open Flexible Composite Mesh Device."

More Recent Ethicon Physiomesh Lawsuit News:

Lawyers for Ethicon Physiomesh Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. OnderLaw has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. OnderLaw has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.